Junshi Biosciences Receives Orphan Medicinal Product Designation from the European Committee for Toripalimab in Treatment of Nasopharyngeal Carcinoma
July 21, 2022
–6th Orphan Drug Designation granted to toripalimab in the US and EU SHANGHAI, China, July